# SapphireDerm Refinement v2 - Executive Summary

## Key Findings

### EPV Validation (g=0)
- **Base Case Equity:** $12,303,304
- **All Assertions:** ✅ PASSED

### Maximum Sustainable Leverage
- **Base Case (≥1.70x DSCR):** 2.00x
- **Low Case (≥1.50x DSCR):** 2.00x

### Price-to-Pass Analysis
- **Maximum Multiple:** 14.99x
- **Binding Constraint:** Base Case DSCR (≥1.70x)

### Feasible Deal Structures
- ❌ No structures pass both DSCR and discipline requirements

### 8.0x Viability Requirements
- **Margin Uplift:** 495 bps
- **Alternative CapEx Cut:** $268,272

## Investment Recommendation

**⚠️ PROCEED WITH CONDITIONS** - operational improvements required
